brevianamide f has been researched along with rifampin in 1 studies
Studies (brevianamide f) | Trials (brevianamide f) | Recent Studies (post-2010) (brevianamide f) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
---|---|---|---|---|---|
18 | 0 | 17 | 20,468 | 1,499 | 6,552 |
Protein | Taxonomy | brevianamide f (IC50) | rifampin (IC50) |
---|---|---|---|
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
Caspase-1 | Homo sapiens (human) | 8.319 | |
Alpha-synuclein | Homo sapiens (human) | 7.1 | |
Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerwick, WH; Hou, XM; Shao, CL; Wang, CY | 1 |
1 review(s) available for brevianamide f and rifampin
Article | Year |
---|---|
Marine natural products as potential anti-tubercular agents.
Topics: Animals; Antitubercular Agents; Aquatic Organisms; Biological Products; Humans; Tuberculosis | 2019 |